Literature DB >> 11480765

The 22q11.2 deletion syndrome.

B S Emanuel1, D McDonald-McGinn, S C Saitta, E H Zackai.   

Abstract

Estimates suggest that the 22q11.2 deletion occurs in approximately 1 in 4000 live births, making this disorder a significant health concern in the general population. The 22q11.2 deletion has been identified in the majority of patients with DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face syndrome, suggesting that they are phenotypic variants of the same disorder. The findings associated with the 22q11.2 deletion are extensive and highly variable from patient to patient. In this chapter, we discuss the features of this disorder, with an emphasis on the clinical findings and an approach to the evaluation of these patients. In addition, we present the current understanding at the molecular level, of the genomic mechanisms and genes that are likely to play a central role in causing this frequent genetic condition.

Entities:  

Mesh:

Year:  2001        PMID: 11480765

Source DB:  PubMed          Journal:  Adv Pediatr        ISSN: 0065-3101


  34 in total

1.  Temporal lobe pleomorphic xanthoastrocytoma and acquired BRAF mutation in an adolescent with the constitutional 22q11.2 deletion syndrome.

Authors:  Jeffrey C Murray; David J Donahue; Saleem I Malik; Yvette B Dzurik; Emily Z Braly; Margaret J Dougherty; Katherine W Eaton; Jaclyn A Biegel
Journal:  J Neurooncol       Date:  2010-08-21       Impact factor: 4.130

2.  Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.

Authors:  Anne M Moon; Deborah L Guris; Ji-heui Seo; Leiming Li; Jennetta Hammond; Amy Talbot; Akira Imamoto
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

3.  MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q.

Authors:  J A S Vorstman; G R Jalali; E F Rappaport; A M Hacker; C Scott; B S Emanuel
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

4.  Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients.

Authors:  Jelena S Arnold; Evan M Braunstein; Takahiro Ohyama; Andrew K Groves; Joe C Adams; M Christian Brown; Bernice E Morrow
Journal:  Hum Mol Genet       Date:  2006-04-06       Impact factor: 6.150

5.  Primary amenorrhea and absent uterus in the 22q11.2 deletion syndrome.

Authors:  Usha T Sundaram; Donna M McDonald-McGinn; Dale Huff; Beverly S Emanuel; Elaine H Zackai; Deborah A Driscoll; Joann Bodurtha
Journal:  Am J Med Genet A       Date:  2007-09-01       Impact factor: 2.802

Review 6.  From microscopes to microarrays: dissecting recurrent chromosomal rearrangements.

Authors:  Beverly S Emanuel; Sulagna C Saitta
Journal:  Nat Rev Genet       Date:  2007-11       Impact factor: 53.242

7.  Deletion 22q11.2: report of a complex meiotic mechanism of origin.

Authors:  Sintia Iole Nogueira; April M Hacker; Fernanda T S Bellucco; Leslie Domenici Kulikowski; Denise Maria Christofolini; Mirlene C Cernach; Maria Isabel Melaragno; Beverly S Emanuel
Journal:  Am J Med Genet A       Date:  2007-08-01       Impact factor: 2.802

8.  Domain specific attentional impairments in children with chromosome 22q11.2 deletion syndrome.

Authors:  Joel P Bish; Renee Chiodo; Victoria Mattei; Tony J Simon
Journal:  Brain Cogn       Date:  2007-05-11       Impact factor: 2.310

9.  Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion.

Authors:  Sulagna C Saitta; Stacy E Harris; Ann P Gaeth; Deborah A Driscoll; Donna M McDonald-McGinn; Melissa K Maisenbacher; Jill M Yersak; Prabir K Chakraborty; April M Hacker; Elaine H Zackai; Terry Ashley; Beverly S Emanuel
Journal:  Hum Mol Genet       Date:  2003-12-17       Impact factor: 6.150

10.  The Severity of Vestibular Dysfunction in Deafness as a Determinant of Comorbid Hyperactivity or Anxiety.

Authors:  Michelle W Antoine; Sarath Vijayakumar; Nicholas McKeehan; Sherri M Jones; Jean M Hébert
Journal:  J Neurosci       Date:  2017-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.